Comirnaty RTU (bivalent, Original/Omicron BA.1)
(Note 2)Partial Change ApprovalCoronavirus Modified Uridine RNA Vaccine (SARS-CoV-2) (active ingredients: tozinameran and riltozinameran)
Approval Information
Brand NameComirnaty RTU
(bivalent, Original/Omicron BA.1)
Generic NameCoronavirus Modified Uridine RNA Vaccine (SARS-CoV-2)
(active ingredients: tozinameran and riltozinameran)
ApprovedSeptember 2022
Type(Note 2)Partial Change Approval
Want structured data, translation summaries & alerts?
PharmaLens is building the most comprehensive English-language PMDA intelligence platform. Join the waitlist for early access.
Join the WaitlistSource: PMDA Website. Review reports are provided under Japan's Public Data License v1.0. Translations and structured data by PharmaLens are unofficial and for reference only.